Still Climbin': An Intervention to Improve Coping Among Black Sexual Minority Men

NCT04587869 — Not applicable, Terminated, 369 participants, RAND

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Still Climbin': A Randomized Controlled Trial to Improve Coping, Medical Mistrust, and Healthcare Engagement Among Black Sexual Minority Men

RegistryNCT04587869
StatusTerminated - NIH terminated the study due to shifted policy priorities
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, prevention
Enrollment369 (Actual)
SponsorRAND (Other); collaborators: University of Massachusetts, Boston, University of Southern California, APLA Health
ConditionsDiscrimination, Social, Health Care Utilization
InterventionsCBT Coping Intervention (Behavioral)
Datesstart 2021-02-09, primary completion 2025-03-20, completion 2025-03-20, first posted 2020-10-14, last updated 2025-11-13
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Discrimination, Social All trials for Health Care Utilization All trials of CBT Coping Intervention

-Summary

This study consists of a randomized controlled trial of a multi-session cognitive behavior therapy (CBT) group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM). Primary intervention objectives include increasing health care engagement and receipt of evidence-based preventive care, as well as better coping and reduced anticipated and internalized stigma, and medical mistrust among intervention participants.

Expand all sections  ·  Collapse all

+Detailed description

This study is a randomized controlled trial of Still Climbin', an 8-session cognitive behavior therapy (CBT) group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM). Designed to be flexible for use in community settings, this intervention was developed in partnership with community stakeholders who emphasized the need for a community-based program outside of the health care system, and without a specific disease focus. It intends to give Black SMM a safe space to receive support for the whole of their identity and to openly discuss barriers to health care. Participants will be followed for 12 months. The effectiveness of the Still Climbin' intervention will be assessed on health care engagement and receipt of evidence-based preventive care, through surveys administered at multiple points throughout the intervention period. These outcomes will be confirmed with information from medical records. A total of 370 Black participants will be recruited and randomly assign 185 to receive the coping intervention and 185 to a no-treatment control. There will be about 10 groups of about 15 participants each for both intervention and control. Participants will be randomized to an intervention or control group after they complete the baseline survey. Participants will complete four surveys, starting with the baseline survey, and followed by 4-, 8-, and 12-month post-baseline follow-up surveys to assess health care engagement and receipt of evidence-based preventive care (e.g., cancer and diabetes screening, cardiovascular disease prevention, influenza vaccination, HIV prevention), and other topics such as coping strategies, stigma, and discrimination. The intervention is hypothesized to show increased health care engagement and receipt of evidence-based preventive care, in addition to better coping and reduced medical mistrust than the control group.

+Arms and interventions

ArmTypeInterventionsDescription
InterventionExperimentalBehavioral: CBT Coping InterventionThe intervention is an 8-session cognitive behavior therapy (CBT) group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM).
No-treatment controlNo interventionParticipants who are assigned to the control group will not receive the intervention.
  • CBT Coping Intervention (Behavioral): A cognitive behavior therapy group intervention that addresses coping with discrimination and medical mistrust among Black sexual minority men (SMM).

+Outcome measures

Primary outcomes

  • Inadequate Healthcare Utilization [baseline to 12-month post-baseline]: Indicator that the individual reported (1) fewer than 1 ambulatory visit AND (2) at least 1 emergency department visit (without subsequent hospitalization) or at least 1 hospitalization in the past 4 months at any of the 3 follow-up assessments (4, 8, and 12 months post-baseline)
  • Proportion of Evidence-based Care Components Received Across Follow-up Assessments [baseline to 12 months post-baseline]: For each individual, this measure is the number of components that were received at any time across the 3 follow-up assessments divided by the number of components they were eligible for at any time across the 3 follow-up assessments, expressed as a proportion. 25 components were evaluated and eligibility for each component varies by individual and follow-up period.

Secondary outcomes

  • Adaptive Coping Strategies (Social Support Seeking) [4-, 8-, and 12-months post-baseline]: Average adaptive coping rating on the Brief COPE scale, social support items (higher=better coping; range=1-4)

+Eligibility

Sex: Male, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

* 18 years of age or older
* Biologically male at birth
* Identify as male
* Self-identify as a Black/African American
* Report having sex with men in the past 24 months
* Anticipate being available for the next 12 months to attend study visits
* Able to interact and communicate in written and spoken English.

Exclusion Criteria:

* Unwilling/Unable to provide informed consent
* Cisgender women
* Transgender women
* Transgender men

+Posted results

Participant flow

MilestoneInterventionNo-treatment Control
Started171198
Completed125137
Not completed4661

Outcome results

  • Inadequate Healthcare Utilization (Primary), Count of participants, Participants: Intervention 41; No-treatment Control 39 (p .44)
  • Proportion of Evidence-based Care Components Received Across Follow-up Assessments (Primary), Mean, proportion: Intervention .46 +/- .22; No-treatment Control .47 +/- .23 (p .47)
  • Adaptive Coping Strategies (Social Support Seeking) (Secondary), Mean, units on a scale (range 1-4): Intervention 2.60 +/- 0.96; No-treatment Control 2.50 +/- 0.96 (p .02)

Adverse events

Time frame: 1 year

ArmDeathsSerious adverse eventsOther adverse events
Intervention1/171 (0.6%)22/171 (12.9%)0/171 (0.0%)
No-treatment Control0/198 (0.0%)17/198 (8.6%)0/198 (0.0%)

Serious adverse events by term

TermOrgan systemInterventionNo-treatment Control
Stroke and other nervous system disorderNervous system disorders6/1712/198
Cardiac-related hospitalizationCardiac disorders5/1713/198
GI related hospitalizationGastrointestinal disorders1/1711/198
Respiratory related hospitalizationRespiratory, thoracic and mediastinal disorders3/1713/198
Infection - hospitalizationInfections and infestations2/1711/198
AccidentsInjury, poisoning and procedural complications4/1712/198
General -surgery due to pre-existing conditionsSurgical and medical procedures1/1714/198
Kidney failureRenal and urinary disorders0/1711/198
General hospitalizationSurgical and medical procedures1/1710/198

+Locations (1)

FacilityCityCountryStatus
APLA HealthLos Angeles, CaliforniaUnited States

+Study documents

+Investigators